T. Rowe Price logo

T. Rowe Price

North America, Maryland, United States, Baltimore

Description

T. Rowe Price is a globally recognized independent investment management firm, headquartered in Baltimore, Maryland, with a long history primarily focused on public equities and fixed income. While not a traditional early-stage venture capital firm, the company has established a substantial presence in the private markets, particularly through its growth equity strategies. They act as a significant crossover investor, deploying capital into late-stage, high-growth technology companies that are often on the cusp of an initial public offering (IPO) or other major liquidity events. Their investment approach is characterized by deep fundamental research and a long-term perspective, aiming to partner with companies that have proven business models, strong management teams, and significant market opportunities.

The firm's private investments typically target companies that have already achieved considerable scale and revenue, distinguishing them from seed or Series A investors. T. Rowe Price often participates in, and frequently leads, large funding rounds for established private technology firms. For instance, they led a $250 million Series E round for Databricks in 2019, demonstrating their capacity to deploy substantial capital into promising ventures. Their portfolio includes numerous high-profile tech unicorns such as Snowflake, Airbnb, DoorDash, and Stripe, where they have often been key participants in multi-hundred-million-dollar funding rounds.

Given their strategic focus on growth equity, the typical "first check" from T. Rowe Price is significantly larger than those from early-stage venture capitalists. Their initial investments in a company generally range from approximately $25 million to upwards of $250 million, depending on the company's stage, capital needs, and the overall size of the funding round. This substantial check size reflects their preference for taking meaningful stakes in mature private companies, leveraging their extensive capital base, which manages over $1.4 trillion in assets globally as of December 31, 2023. They are a crucial source of capital for companies seeking to scale rapidly and prepare for public market entry.

Investor Profile

T. Rowe Price has backed more than 346 startups, with 18 new investments in the last 12 months alone. The firm has led 89 rounds, about 26% of its total and boasts 141 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series D, Series B rounds (top funding stages).
  • Majority of deals are located in United States, India, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 4 rounds in the past year.
  • Typical check size: $25M – $250M.

Stage Focus

  • Series C (17%)
  • Series D (16%)
  • Series B (11%)
  • Series E (10%)
  • Series Unknown (9%)
  • Series F (9%)
  • Private Equity (8%)
  • Post Ipo Equity (6%)
  • Series G (5%)
  • Series A (3%)

Country Focus

  • United States (92%)
  • India (2%)
  • United Kingdom (1%)
  • Australia (1%)
  • Canada (1%)
  • Germany (1%)
  • France (1%)
  • China (1%)
  • Colombia (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Software
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Pharmaceutical
  • Life Science
  • Saas
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does T. Rowe Price frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 28
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 30
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 24
Dragoneer Investment Group
North America, California, United States, San Francisco
Co-Investments: 24
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 27
BlackRock
North America, New York, United States, New York
Co-Investments: 33
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 26
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 31
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 34
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 96

Which angels does T. Rowe Price often collaborate with?

MV
North America, Washington, United States, Seattle
Shared Deals: 2
Shared Deals: 1
ES
North America, California, United States, Mountain View
Shared Deals: 3
JL
North America, United States
Shared Deals: 1
AG
North America, New Jersey, United States, New Brunswick
Shared Deals: 1
SS
North America, California, United States, Los Angeles
Shared Deals: 2
BN
North America, Massachusetts, United States, Boston
Shared Deals: 1
OV
North America, California, United States, San Francisco
Shared Deals: 1
David J. Adelman
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 2
SP
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by T. Rowe Price?

Tango Therapeutics

Cambridge, Massachusetts, United States

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo EquityOct 23, 2025
Amount Raised: $197,000,000
Crusoe Energy Systems

Denver, Colorado, United States

Crusoe is a vertically integrated AI infrastructure company that builds and operates data centers powered by energy sources.

Artificial Intelligence (AI)EnergyEnergy ManagementOil and Gas
Series EOct 23, 2025
Amount Raised: $1,400,000,000
Kardigan

South San Francisco, California, United States

Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

BiopharmaHealth CareMedical
Series BOct 14, 2025
Amount Raised: $254,000,000
Kailera Therapeutics

Waltham, Massachusetts, United States

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

BiotechnologyPharmaceuticalTherapeutics
Series BOct 14, 2025
Amount Raised: $600,000,000
First Abu Dhabi Bank

Dubai, Dubai, United Arab Emirates

First Abu Dhabi Bank offers comprehensive banking services, including personal and corporate solutions.

BankingFinanceFinancial ServicesLending
Post Ipo DebtOct 9, 2025
Amount Raised: $20,000,000
OpenAI

San Francisco, California, United States

OpenAI is an AI research and deployment company that develops advanced AI models, including ChatGPT.

Artificial Intelligence (AI)Generative AIMachine LearningNatural Language ProcessingSaaS
Secondary MarketOct 2, 2025
Amount Raised: $6,600,000,000
PsiQuantum

Palo Alto, California, United States

PsiQuantum focuses on developing a scalable quantum computer using photonic qubits.

ComputerHardwareQuantum ComputingSemiconductorSoftware
Series ESep 10, 2025
Amount Raised: $1,000,000,000
Treeline Biosciences

Watertown, Massachusetts, United States

Treeline Biosciences is a biotech company building transformative precision medicines for patients with cancer and other serious conditions.

BiotechnologyHealth CareLife ScienceMedicalPrecision Medicine
Series ASep 3, 2025
Amount Raised: $200,000,000
Galvanize Therapeutics

San Carlos, California, United States

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

Health CareMedicalMedical DeviceTherapeutics
Series CSep 3, 2025
Amount Raised: $100,000,000
Anthropic

San Francisco, California, United States

Anthropic is an AI research company that focuses on the safety and alignment of AI systems with human values.

Artificial Intelligence (AI)Generative AIInformation TechnologyMachine Learning
Series FSep 2, 2025
Amount Raised: $13,000,000,000